CareerPlanSign in
This role has closed. Browse similar live roles below, or see all open jobs →

Study Start Up Manager

US💼 Full-time💰 $120,355–$120,355🗓 2026-08-25 → 2026-09-25

Core

Lead country-level clinical study start-up activities to accelerate site activations, manage regulatory/ethics submissions, and ensure compliance with ICH-GCP and local regulations.

Role type

Senior Clinical Study Start-Up Lead

Builds

Clinical trial start-up infrastructure and site readiness for AstraZeneca medicines

Domain

Life Sciences / Clinical Operations

Deliverable

production ML models | product features | dashboards & analysis | client delivery | infrastructure | physical/clinical work

Required skills

Clinical study start-up leadership, Regulatory documentation management, Authority and ethics submissions, Feasibility and planning, Cross-functional collaboration, Systems and data integrity, eTMF quality management, Risk and performance management, Veeva Vault, Informed consent review, Language negotiation, Clinical trial process knowledge (Phases II–IV), ICH GCP, Project management, Vendor management

Preferred skills

Multi-center/multi-country start-up leadership, Direct interaction with ethics committees/health authorities, eClinical ecosystem familiarity, Playbook/KPI design, Additional languages

Technologies

Veeva Vault, CTMS, eTMF

Responsibilities

Own all start-up activities at the country level ensuring compliance; Serve as main point of contact for sites leading informed consent reviews and language negotiations; Prepare and manage site and country regulatory documentation; Lead submissions to Regulatory Authorities and IEC/IRB; Contribute to clinical and operational feasibility assessments; Partner with CRAs and Local Study Team to achieve milestones; Update CTMS with accurate site data; Ensure eTMF document collection and QC; Proactively manage outstanding actions and report on milestones/risks.

Seniority

Senior, hands-on IC

Sourced via workday · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.